Tapentadol is partly metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that increase or repress the action/expression of a number of of those enzymes, and with substrates of such enzymes (because of Level of competition for the enzyme); some enzyme mediators/substrates call https://johne329bcd9.wikifiltraciones.com/user